The WACC of NantHealth Inc (NH) is 5.7%.
Range | Selected | |
Cost of equity | 6.7% - 20.7% | 13.7% |
Tax rate | 0.4% - 0.5% | 0.45% |
Cost of debt | 4.0% - 7.0% | 5.5% |
WACC | 4.1% - 7.4% | 5.7% |
Category | Low | High |
Long-term bond rate | 4.2% | 4.7% |
Equity market risk premium | 5.0% | 6.0% |
Adjusted beta | 0.5 | 2.59 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.7% | 20.7% |
Tax rate | 0.4% | 0.5% |
Debt/Equity ratio | 29.54 | 29.54 |
Cost of debt | 4.0% | 7.0% |
After-tax WACC | 4.1% | 7.4% |
Selected WACC | 5.7% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
NH | NantHealth Inc | 29.54 | 0.4 | 0.01 |
APYI | Aspyra Inc | 0.53 | 0.2 | 0.13 |
CMPD | CompuMed Inc | 0.05 | 0.33 | 0.31 |
HLYK | Healthlynked Corp | 0.1 | 1.95 | 1.78 |
KSI.V | Kneat.com Inc | 0.04 | 0.51 | 0.49 |
MDXL | Medixall Group Inc | 4.53 | 225.71 | 40.95 |
MITI | Mitesco Inc | 0.43 | -1.06 | -0.75 |
MPLN | Multiplan Corp | 12.06 | 2.05 | 0.16 |
MTBC | MTBC Inc | 0.17 | 0.85 | 0.72 |
RHT.V | Reliq Health Technologies Inc | 0.01 | 0.99 | 0.98 |
Low | High | |
Unlevered beta | 0.25 | 0.58 |
Relevered beta | 0.25 | 3.37 |
Adjusted relevered beta | 0.5 | 2.59 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for NH:
cost_of_equity (13.70%) = risk_free_rate (4.45%) + equity_risk_premium (5.50%) * adjusted_beta (0.5) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.